Skip to main content
Top
Published in: Archives of Virology 7/2015

01-07-2015 | Original Article

Association of lipid profile alterations with severe forms of dengue in humans

Authors: Anyelo Durán, Rafaela Carrero, Belkis Parra, Andrea González, Lineth Delgado, Jesús Mosquera, Nereida Valero

Published in: Archives of Virology | Issue 7/2015

Login to get access

Abstract

Previous studies have shown a relationship between circulating lipids and dengue virus infection; however, the association of altered lipid profiles with severe dengue remains little studied. The aim of this study was to determine the association between circulating lipid content and severe dengue and/or platelet counts. Ninety-eight patients (2–66 years old) classified as having dengue without warning signs (DNWS), dengue with warning signs (DWWS), or severe dengue (SD) and 62 healthy individuals were studied. Blood samples were tested for NS1, anti-dengue IgM, platelet content, total cholesterol (TC), triglycerides (T), high-density lipoproteins (HDL), low-density lipoproteins (LDL) and very-low-density lipoproteins (VLDL). Lipid alterations were observed mainly in patients with SD. Increased T and VLDL was observed in SD, and increased HDL was observed in DWWS and SD. Decreased TC was found in all forms of dengue, and the lowest LDL values were found in SD. Platelet counts were significantly decreased in DWWS and SD when compare to DNWS. A positive correlation (p = 0.019) between LDL values and platelet counts and a negative correlation (p = 0.0162) between VLDL values and platelet counts were found. Lipid profile alterations were associated with severe dengue.
Literature
1.
go back to reference Normile D (2013) Surprising new dengue virus throws a spanner in disease control efforts. Science 342:415PubMedCrossRef Normile D (2013) Surprising new dengue virus throws a spanner in disease control efforts. Science 342:415PubMedCrossRef
3.
go back to reference Voisset C, Callens N, Blanchard E et al (2005) High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem 280:7793–7799PubMedCrossRef Voisset C, Callens N, Blanchard E et al (2005) High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem 280:7793–7799PubMedCrossRef
4.
go back to reference Andreo U, Maillard P, Kalinina O et al (2007) Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection. Cell Microbiol 9:2445–2456PubMedCrossRef Andreo U, Maillard P, Kalinina O et al (2007) Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection. Cell Microbiol 9:2445–2456PubMedCrossRef
5.
go back to reference Agnello V, Abel G, Elfahal M et al (1999) Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 96:12766–12771PubMedCentralPubMedCrossRef Agnello V, Abel G, Elfahal M et al (1999) Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 96:12766–12771PubMedCentralPubMedCrossRef
6.
go back to reference Andre P, Komurian-Pradel F, Deforges S et al (2002) Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 76:6919–6928PubMedCentralPubMedCrossRef Andre P, Komurian-Pradel F, Deforges S et al (2002) Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 76:6919–6928PubMedCentralPubMedCrossRef
7.
go back to reference Voisset C, Op de Beeck A, Horellou P et al (2006) High density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry. J Gen Virol 87:2577–2581PubMedCrossRef Voisset C, Op de Beeck A, Horellou P et al (2006) High density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry. J Gen Virol 87:2577–2581PubMedCrossRef
8.
go back to reference Van Gorp ECM, Suharti C, Mairuhu ATA et al (2002) Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. Clin Infect Dis 34:1150–1153PubMedCrossRef Van Gorp ECM, Suharti C, Mairuhu ATA et al (2002) Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. Clin Infect Dis 34:1150–1153PubMedCrossRef
10.
go back to reference Villar-Centeno LA, Díaz-Quijano FA, Martínez-Vega RA et al (2008) Biochemical alterations as markers of dengue hemorrhagic fever. Am J Trop Med Hyg 78:370–374PubMed Villar-Centeno LA, Díaz-Quijano FA, Martínez-Vega RA et al (2008) Biochemical alterations as markers of dengue hemorrhagic fever. Am J Trop Med Hyg 78:370–374PubMed
14.
go back to reference Friedewald W, Levy R, Fredrickson D (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed Friedewald W, Levy R, Fredrickson D (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed
16.
go back to reference Stephenson JR (2005) Understanding dengue pathogenesis: implications for vaccine design. Bull World Health Organ 83:308–314PubMedCentralPubMed Stephenson JR (2005) Understanding dengue pathogenesis: implications for vaccine design. Bull World Health Organ 83:308–314PubMedCentralPubMed
17.
go back to reference Mongkolsapaya J, Dejnirattisai W, Xu XN et al (2003) Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9:921–927PubMedCrossRef Mongkolsapaya J, Dejnirattisai W, Xu XN et al (2003) Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9:921–927PubMedCrossRef
18.
go back to reference Dejnirattisai W, Jumnainsong A, Onsirisakul N et al (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745–748PubMedCrossRef Dejnirattisai W, Jumnainsong A, Onsirisakul N et al (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745–748PubMedCrossRef
19.
go back to reference Stephens HA (2010) HLA and other gene associations with dengue disease severity. Curr Top Microbiol Immunol 338:99–114PubMed Stephens HA (2010) HLA and other gene associations with dengue disease severity. Curr Top Microbiol Immunol 338:99–114PubMed
20.
go back to reference Lye DC, Lee VJ, Sun Y et al (2010) The benign nature of acute dengue infection in hospitalized older adults in Singapore. Int J Infect Dis 14:e410–e413PubMedCrossRef Lye DC, Lee VJ, Sun Y et al (2010) The benign nature of acute dengue infection in hospitalized older adults in Singapore. Int J Infect Dis 14:e410–e413PubMedCrossRef
22.
go back to reference Guevara J, Prashad N, Ermolinksy B et al (2010) Apo B100 similarities to viral proteins suggest basis for LDL-DNA binding and transfection capacity. J Lipid Res 51:1704–1718PubMedCentralPubMedCrossRef Guevara J, Prashad N, Ermolinksy B et al (2010) Apo B100 similarities to viral proteins suggest basis for LDL-DNA binding and transfection capacity. J Lipid Res 51:1704–1718PubMedCentralPubMedCrossRef
23.
go back to reference Soto-Acosta R, Mosso C, Cervantes-Salazar M et al (2013) The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity. Virology 442:132–147PubMedCrossRef Soto-Acosta R, Mosso C, Cervantes-Salazar M et al (2013) The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity. Virology 442:132–147PubMedCrossRef
25.
go back to reference Carro AC, Damonte EB (2013) Requirement of cholesterol in the viral envelope for dengue virus infection. Virus Res 174:78–87PubMedCrossRef Carro AC, Damonte EB (2013) Requirement of cholesterol in the viral envelope for dengue virus infection. Virus Res 174:78–87PubMedCrossRef
27.
go back to reference Rothwell C, LeBreton A, Ng CY et al (2009) Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 389:8–19PubMedCrossRef Rothwell C, LeBreton A, Ng CY et al (2009) Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 389:8–19PubMedCrossRef
29.
30.
go back to reference Nowack R, Wiedemann G (2010) Pancytopenia with severe thrombocytopenia in a patient treated with twice-weekly LDL-apheresis by polyacrylate adsorption from whole blood. J Clin Apheresis 25:77–80PubMed Nowack R, Wiedemann G (2010) Pancytopenia with severe thrombocytopenia in a patient treated with twice-weekly LDL-apheresis by polyacrylate adsorption from whole blood. J Clin Apheresis 25:77–80PubMed
31.
go back to reference Shahbazian H, Mohtashami AZ, Ghorbani A et al (2011) Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial. Nefrologia 31:58–65. doi:10.3265/Nefrologia.pre2010 PubMed Shahbazian H, Mohtashami AZ, Ghorbani A et al (2011) Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial. Nefrologia 31:58–65. doi:10.​3265/​Nefrologia.​pre2010 PubMed
32.
go back to reference Dole VD, Matuskova J, Vasile E et al (2008) Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor–deficient mice. Arterioscler Thromb Vasc Biol 28:1111–1116PubMedCentralPubMedCrossRef Dole VD, Matuskova J, Vasile E et al (2008) Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor–deficient mice. Arterioscler Thromb Vasc Biol 28:1111–1116PubMedCentralPubMedCrossRef
33.
go back to reference Lin Z-W, Ho H-C, Yang C-H et al (2009) Rosuvastatin-induced thrombocytopenic purpura. Dermatol Sin 27:235–240 Lin Z-W, Ho H-C, Yang C-H et al (2009) Rosuvastatin-induced thrombocytopenic purpura. Dermatol Sin 27:235–240
34.
go back to reference Leaf DA (2008) Hypertriglyceridemia: a guide to assessment and treatment. Hosp Phys 32:17–23 Leaf DA (2008) Hypertriglyceridemia: a guide to assessment and treatment. Hosp Phys 32:17–23
35.
go back to reference Faivre L, Saugier-Veber P, Pais de Barros JP et al (2005) Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation. Eur J Hum Genet 13:1186–1191PubMedCrossRef Faivre L, Saugier-Veber P, Pais de Barros JP et al (2005) Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation. Eur J Hum Genet 13:1186–1191PubMedCrossRef
37.
go back to reference Ly H, Francone OL, Fielding CJ et al (1995) Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J Lipid Res 36:1254–1263PubMed Ly H, Francone OL, Fielding CJ et al (1995) Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J Lipid Res 36:1254–1263PubMed
38.
go back to reference Ettinger WH, Varma VK, Sorci-Thomas M et al (1994) Cytokines decrease apolipoprotein accumulation in medium from HepG2 cells. Arterioscler Thromb 14:8–13PubMedCrossRef Ettinger WH, Varma VK, Sorci-Thomas M et al (1994) Cytokines decrease apolipoprotein accumulation in medium from HepG2 cells. Arterioscler Thromb 14:8–13PubMedCrossRef
Metadata
Title
Association of lipid profile alterations with severe forms of dengue in humans
Authors
Anyelo Durán
Rafaela Carrero
Belkis Parra
Andrea González
Lineth Delgado
Jesús Mosquera
Nereida Valero
Publication date
01-07-2015
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 7/2015
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-015-2433-z

Other articles of this Issue 7/2015

Archives of Virology 7/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.